Super Micro (SMCI) stock jumps 5% in Thursday trade — what’s moving the price now

Super Micro (SMCI) stock jumps 5% in Thursday trade — what’s moving the price now

February 19, 2026

New York, Feb 19, 2026, 11:46 EST — Regular session

  • Super Micro Computer shares are up roughly 5.5% in late-morning trading, outperforming a weaker broader market.
  • After dropping for two straight sessions, the stock bounces as attention shifts back to AI infrastructure spending.
  • Margins are in focus, with investors also looking for updated demand commentary before the early-March meetings.

Super Micro Computer Inc climbed roughly 5.5% to $31.35 late Thursday morning, bouncing back after earlier-week declines. Shares peaked at $32.07 during the session, with around 23.9 million shares changing hands.

Super Micro now acts as a sort of litmus test for AI-driven data-center investment, and investors haven’t hesitated to ding the stock at the first sign that expansion might be eating into margins. On this day, the S&P 500 tracking ETF SPY slipped roughly 0.3%, which only highlighted just how much the stock was outpacing the broader market.

The AI supply chain remains in focus following Nvidia’s announcement of a multiyear agreement with Meta Platforms to supply millions of both existing and upcoming AI chips—specifically Blackwell, the soon-to-arrive Rubin, as well as Grace and Vera processors. “Meta has already had a chance to get on Vera,” said Ian Buck, who heads Nvidia’s hyperscale and high-performance computing unit. Reuters

Super Micro shares slipped another 1.33% Wednesday, settling at $29.71, according to MarketWatch data. That marked the second loss in as many sessions. The stock is still trading well under its 52-week peak of $66.44. MarketWatch

Super Micro bumped up its fiscal 2026 revenue target to at least $40 billion this month, up from $36 billion, betting on continued appetite for AI-optimized servers as clients boost data-center buildouts. “Order strength remains strong from large global data center and enterprise customers,” CFO David Weigand told analysts after the results. CEO Charles Liang, though, pointed to some immediate margin headwinds—tariffs, costlier facilities, and component shortages. Reuters

Super Micro’s fiscal second-quarter results, covering the stretch through Dec. 31, showed net sales coming in at $12.7 billion, with gross margin at 6.3%, according to the company. That margin—essentially what’s left after the direct costs of manufacturing—has continued to unsettle investors, even with revenue climbing. Looking ahead, Super Micro projected at least $12.3 billion in net sales for the third quarter, and it stuck to its fiscal 2026 target: $40.0 billion or more in sales. Supermicro

But there’s risk on both sides. Should pricing remain tight, components stay scarce, or customers pump the brakes on deployments, shares could quickly lose ground — particularly since fast top-line growth is already priced in by plenty of investors looking at AI-server suppliers.

Coming up for Super Micro: a slate of one-on-one investor meetings kicking off in early March. The company confirmed plans to attend three back-to-back events—Morgan Stanley’s Technology, Media & Telecom Conference on March 2, Keybanc’s Emerging Technology Summit the day after, and then Loop Capital Markets’ investor gathering on March 10. Supermicro

Right now, traders want fresh details on demand, lead times, and pricing from those early-March meetings. Afterward, the big question: Can revenue keep climbing without margins getting squeezed?

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • AstraZeneca Shares Show Valuation Disparities Amid Pipeline Optimism
    June 26, 2026, 7:54 PM EDT. AstraZeneca (LSE:AZN) shares gained 1.8% recently, with a 7-day return of 8.19% and a one-year total shareholder return of 42.48%, reflecting strong momentum. Trading at £143.18, the stock shows a 38.06% intrinsic discount against a fair value estimate of £164.85 based on future cash flows, signalling potential undervaluation. The company's diversified late-stage pipeline, especially in oncology and rare diseases, forecasts over $10 billion in peak risk-adjusted revenue, supporting long-term growth. However, risks include reliance on blockbuster drugs and increasing government price controls. Notably, AstraZeneca's price-to-earnings ratio (28.2x) surpasses the industry average (21.3x), highlighting mixed valuation signals between cash flow models and earnings multiples. Investors face a key question: weigh discounted cash flows or premium earnings multiple in assessing the stock's fairness.